Cambrian Capital Partners

Cambrian Capital Partners is a private equity firm established in 2019 and based in Edmonton, Canada. The firm specializes in offering off-market and creative investment solutions, primarily targeting lower mid-market companies. Cambrian Capital Partners focuses its investments in the building materials, agriculture, and agricultural technology sectors, seeking to identify opportunities that align with its strategic vision.

Bill Schmitt

Partner

2 past transactions

CND Life Sciences

Series A in 2025
CND Life Sciences is a medical diagnostics company focused on developing innovative tools for the diagnosis of neurodegenerative diseases, particularly synucleinopathies such as Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure. The company has introduced the Syn-One Test, an evidence-based diagnostic tool that detects, visualizes, and quantifies abnormal, phosphorylated alpha-synuclein in cutaneous nerve fibers. This test provides medical professionals with a convenient, accurate, and minimally invasive method to confirm the presence of synucleinopathy in patients, addressing a critical need for reliable diagnostic options in the field of neurology.

CND Life Sciences

Seed Round in 2022
CND Life Sciences is a medical diagnostics company focused on developing innovative tools for the diagnosis of neurodegenerative diseases, particularly synucleinopathies such as Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure. The company has introduced the Syn-One Test, an evidence-based diagnostic tool that detects, visualizes, and quantifies abnormal, phosphorylated alpha-synuclein in cutaneous nerve fibers. This test provides medical professionals with a convenient, accurate, and minimally invasive method to confirm the presence of synucleinopathy in patients, addressing a critical need for reliable diagnostic options in the field of neurology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.